These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 22362820)
1. Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol. Cornel KM; Kruitwagen RF; Delvoux B; Visconti L; Van de Vijver KK; Day JM; Van Gorp T; Hermans RJ; Dunselman GA; Romano A J Clin Endocrinol Metab; 2012 Apr; 97(4):E591-601. PubMed ID: 22362820 [TBL] [Abstract][Full Text] [Related]
2. Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach. Konings GF; Cornel KM; Xanthoulea S; Delvoux B; Skowron MA; Kooreman L; Koskimies P; Krakstad C; Salvesen HB; van Kuijk K; Schrooders YJ; Vooijs M; Groot AJ; Bongers MY; Kruitwagen RF; ; Romano A J Pathol; 2018 Feb; 244(2):203-214. PubMed ID: 29144553 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of 17β-hydroxysteroid dehydrogenase impairs human endometrial cancer growth in an orthotopic xenograft mouse model. Xanthoulea S; Konings GFJ; Saarinen N; Delvoux B; Kooreman LFS; Koskimies P; Häkkinen MR; Auriola S; D'Avanzo E; Walid Y; Verhaegen F; Lieuwes NG; Caiment F; Kruitwagen R; ; Romano A Cancer Lett; 2021 Jun; 508():18-29. PubMed ID: 33762202 [TBL] [Abstract][Full Text] [Related]
4. Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain. Steckelbroeck S; Watzka M; Reissinger A; Wegener-Toper P; Bidlingmaier F; Bliesener N; Hans VH; Clusmann H; Ludwig M; Siekmann L; Klingmüller D J Steroid Biochem Mol Biol; 2003 Jul; 86(1):79-92. PubMed ID: 12943747 [TBL] [Abstract][Full Text] [Related]
5. The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma. Utsunomiya H; Suzuki T; Kaneko C; Takeyama J; Nakamura J; Kimura K; Yoshihama M; Harada N; Ito K; Konno R; Sato S; Okamura K; Sasano H J Clin Endocrinol Metab; 2001 Jul; 86(7):3436-43. PubMed ID: 11443221 [TBL] [Abstract][Full Text] [Related]
6. Differential estrogenic 17beta-hydroxysteroid dehydrogenase activity and type 12 17beta-hydroxysteroid dehydrogenase expression levels in preadipocytes and differentiated adipocytes. Bellemare V; Laberge P; Noël S; Tchernof A; Luu-The V J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):129-34. PubMed ID: 19429442 [TBL] [Abstract][Full Text] [Related]
7. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796 [TBL] [Abstract][Full Text] [Related]
8. [Effect of gestagen therapy upon estradiol- and progesterone-receptor-level and 17beta-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma (author's transl)]. Pollow K; Boquoi E Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):231-42. PubMed ID: 185824 [TBL] [Abstract][Full Text] [Related]
9. 17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders. Ito K; Utsunomiya H; Suzuki T; Saitou S; Akahira J; Okamura K; Yaegashi N; Sasano H Mol Cell Endocrinol; 2006 Mar; 248(1-2):136-40. PubMed ID: 16406263 [TBL] [Abstract][Full Text] [Related]
10. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines. Smuc T; Rizner TL Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235 [TBL] [Abstract][Full Text] [Related]
11. Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells. Zhang CY; Wang WQ; Chen J; Lin SX J Steroid Biochem Mol Biol; 2015 Jun; 150():24-34. PubMed ID: 25257817 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of type 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions. Delvoux B; D'Hooghe T; Kyama C; Koskimies P; Hermans RJ; Dunselman GA; Romano A J Clin Endocrinol Metab; 2014 Jan; 99(1):276-84. PubMed ID: 24187399 [TBL] [Abstract][Full Text] [Related]
13. High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer. Cornel KM; Krakstad C; Delvoux B; Xanthoulea S; Jori B; Bongers MY; Konings GF; Kooreman LF; Kruitwagen RF; Salvesen HB; ; Romano A Mol Cell Endocrinol; 2017 Feb; 442():51-57. PubMed ID: 27923582 [TBL] [Abstract][Full Text] [Related]
14. A novel 17β-hydroxysteroid dehydrogenase in Rhodococcus sp. P14 for transforming 17β-estradiol to estrone. Ye X; Wang H; Kan J; Li J; Huang T; Xiong G; Hu Z Chem Biol Interact; 2017 Oct; 276():105-112. PubMed ID: 28619386 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of type I 17beta-hydroxysteroid dehydrogenase enhances in situ production of estradiol in uterine leiomyoma. Kasai T; Shozu M; Murakami K; Segawa T; Shinohara K; Nomura K; Inoue M J Clin Endocrinol Metab; 2004 Nov; 89(11):5661-8. PubMed ID: 15531526 [TBL] [Abstract][Full Text] [Related]
16. Characterization of 17β-hydroxysteroid dehydrogenase and regulators involved in estrogen degradation in Pseudomonas putida SJTE-1. Wang P; Zheng D; Peng W; Wang Y; Wang X; Xiong W; Liang R Appl Microbiol Biotechnol; 2019 Mar; 103(5):2413-2425. PubMed ID: 30623203 [TBL] [Abstract][Full Text] [Related]
18. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12). Fournier MA; Poirier D Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841 [TBL] [Abstract][Full Text] [Related]
19. 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer. Hashimoto C; Miki Y; Tanaka S; Takagi K; Fue M; Doe Z; Li B; Yaegashi N; Suzuki T; Ito K Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642629 [TBL] [Abstract][Full Text] [Related]
20. Steroid-converting enzymes in human ovarian carcinomas. Chura JC; Ryu HS; Simard M; Poirier D; Tremblay Y; Brooker DC; Blomquist CH; Argenta PA Mol Cell Endocrinol; 2009 Mar; 301(1-2):51-8. PubMed ID: 18723074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]